• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

转移机制。

Mechanisms of metastasis.

作者信息

Hunter Kent W, Crawford Nigel P S, Alsarraj Jude

机构信息

Laboratory of Cancer Biology and Genetics, Center for Cancer Research, NCI, NIH, Bethesda, Maryland 20892-4264, USA.

出版信息

Breast Cancer Res. 2008;10 Suppl 1(Suppl 1):S2. doi: 10.1186/bcr1988.

DOI:10.1186/bcr1988
PMID:19091006
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2605099/
Abstract

Metastasis is an enormously complex process that remains to be a major problem in the management of cancer. The fact that cancer patients might develop metastasis after years or even decades from diagnosis of the primary tumor makes the metastatic process even more complex. Over the years many hypotheses were developed to try to explain the inefficiency of the metastatic process, but none of these theories completely explains the current biological and clinical observations. In this review we summarize some of the proposed models that were developed in attempt to understand the mechanisms of tumor dissemination and colonization as well as metastatic progression.

摘要

转移是一个极其复杂的过程,仍然是癌症治疗中的一个主要问题。癌症患者在原发性肿瘤诊断后的数年甚至数十年后可能发生转移,这一事实使得转移过程更加复杂。多年来,人们提出了许多假说,试图解释转移过程的低效性,但这些理论都没有完全解释当前的生物学和临床观察结果。在这篇综述中,我们总结了一些为试图理解肿瘤播散、定植以及转移进展机制而提出的模型。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9d64/2605099/b7d81c4d9702/bcr1988-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9d64/2605099/2e5d491dd5db/bcr1988-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9d64/2605099/b7d81c4d9702/bcr1988-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9d64/2605099/2e5d491dd5db/bcr1988-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9d64/2605099/b7d81c4d9702/bcr1988-2.jpg

相似文献

1
Mechanisms of metastasis.转移机制。
Breast Cancer Res. 2008;10 Suppl 1(Suppl 1):S2. doi: 10.1186/bcr1988.
2
Concepts of metastasis in flux: the stromal progression model.转移概念的转变:基质演进模型。
Semin Cancer Biol. 2012 Jun;22(3):174-86. doi: 10.1016/j.semcancer.2012.02.007. Epub 2012 Feb 21.
3
The intersection of inheritance and metastasis: the role and implications of germline polymorphism in tumor dissemination.遗传与转移的交叉点:种系多态性在肿瘤播散中的作用及影响
Cell Cycle. 2005 Dec;4(12):1719-21. doi: 10.4161/cc.4.12.2258. Epub 2005 Dec 14.
4
Cancer Metastasis: A Reappraisal of Its Underlying Mechanisms and Their Relevance to Treatment.癌症转移:对其潜在机制及其与治疗相关性的再评价。
Annu Rev Pathol. 2018 Jan 24;13:117-140. doi: 10.1146/annurev-pathol-020117-044127. Epub 2017 Oct 25.
5
Metastasis suppression: the evolving role of metastasis suppressor genes for regulating cancer cell growth at the secondary site.转移抑制:转移抑制基因在调控癌细胞在继发部位生长方面不断演变的作用。
J Urol. 2003 Mar;169(3):1122-33. doi: 10.1097/01.ju.0000051580.89109.4b.
6
Tumor progression and metastasis.肿瘤进展与转移。
Carcinogenesis. 2000 Mar;21(3):497-503. doi: 10.1093/carcin/21.3.497.
7
Multi-step cascade of tumor cell metastasis.肿瘤细胞转移的多步骤级联反应。
In Vivo. 1992 Jul-Aug;6(4):309-16.
8
Metastasis: new perspectives on an old problem.转移:一个老问题的新视角。
Mol Cancer. 2011 Feb 22;10:22. doi: 10.1186/1476-4598-10-22.
9
Tumor-endothelial cell interactions: therapeutic potential.肿瘤-内皮细胞相互作用:治疗潜力。
Microvasc Res. 2007 Sep-Nov;74(2-3):114-20. doi: 10.1016/j.mvr.2007.04.002. Epub 2007 Apr 14.
10
Transfer of malignant traits as opposed to migration of cells: A novel concept to explain metastatic disease.恶性特征的转移而非细胞迁移:解释转移性疾病的一个新概念。
Med Hypotheses. 2017 Mar;100:82-86. doi: 10.1016/j.mehy.2017.01.019. Epub 2017 Feb 1.

引用本文的文献

1
Extracorporeal blood filtration leading to tumor growth arrest and reduced analgesic requirements in Stage IV poorly differentiated pancreatic adenocarcinoma: A case report.体外血液滤过导致IV期低分化胰腺腺癌肿瘤生长停滞并降低镇痛需求:一例报告
Oncotarget. 2025 Jul 23;16:582-586. doi: 10.18632/oncotarget.28756.
2
ANKRD17 induces pro-survival signaling pathways that enhance cellular invasion and migration during hepatocellular carcinoma tumorigenesis.锚蛋白重复结构域17(ANKRD17)诱导促生存信号通路,在肝细胞癌发生过程中增强细胞侵袭和迁移能力。
iScience. 2025 Apr 17;28(5):112463. doi: 10.1016/j.isci.2025.112463. eCollection 2025 May 16.
3

本文引用的文献

1
Direct visualization of macrophage-assisted tumor cell intravasation in mammary tumors.乳腺肿瘤中巨噬细胞辅助肿瘤细胞血管内渗的直接可视化。
Cancer Res. 2007 Mar 15;67(6):2649-56. doi: 10.1158/0008-5472.CAN-06-1823.
2
Osteoclast nuclei of myeloma patients show chromosome translocations specific for the myeloma cell clone: a new type of cancer-host partnership?骨髓瘤患者的破骨细胞核显示出特定于骨髓瘤细胞克隆的染色体易位:一种新型的癌症-宿主关系?
J Pathol. 2007 Jan;211(1):10-7. doi: 10.1002/path.2078.
3
Predicting a local recurrence after breast-conserving therapy by gene expression profiling.
Cell fusion as a driver of metastasis: re-evaluating an old hypothesis in the age of cancer heterogeneity.
细胞融合作为转移的驱动因素:在癌症异质性时代重新评估一个古老的假说。
Front Immunol. 2025 Feb 4;16:1524781. doi: 10.3389/fimmu.2025.1524781. eCollection 2025.
4
3D tumor spheroids: morphological alterations a yardstick to anti-cancer drug response.3D肿瘤球体:形态学改变作为抗癌药物反应的衡量标准。
In Vitro Model. 2023 Sep 20;2(6):219-248. doi: 10.1007/s44164-023-00059-8. eCollection 2023 Dec.
5
Unraveling the metastasis-preventing effect of miR-200c in vitro and in vivo.揭示miR-200c在体外和体内的转移预防作用。
Mol Oncol. 2025 Apr;19(4):1029-1053. doi: 10.1002/1878-0261.13712. Epub 2024 Oct 15.
6
Antitumoral and Antimetastatic Activity by Mixed Chelate Copper(II) Compounds (Casiopeínas) on Triple-Negative Breast Cancer, In Vitro and In Vivo Models.混合螯合铜(II)配合物(Casiopeínas)对三阴性乳腺癌的抗肿瘤和抗转移活性:体外和体内模型。
Int J Mol Sci. 2024 Aug 13;25(16):8803. doi: 10.3390/ijms25168803.
7
Learning optimal integration of spatial and temporal information in noisy chemotaxis.学习在有噪声的趋化作用中空间和时间信息的最优整合。
PNAS Nexus. 2024 Jun 14;3(7):pgae235. doi: 10.1093/pnasnexus/pgae235. eCollection 2024 Jul.
8
Targeting the glutamine metabolism to suppress cell proliferation in mesenchymal docetaxel-resistant prostate cancer.靶向谷氨酰胺代谢抑制间质多西紫杉醇耐药性前列腺癌的细胞增殖。
Oncogene. 2024 Jun;43(26):2038-2050. doi: 10.1038/s41388-024-03059-4. Epub 2024 May 15.
9
Molecular perspectives on systemic priming and concomitant immunity in colorectal carcinoma.结直肠癌中系统性启动和伴随免疫的分子观点。
J Egypt Natl Canc Inst. 2024 Mar 11;36(1):7. doi: 10.1186/s43046-024-00211-9.
10
Liver tropism of ER mutant breast cancer is characterized by unique molecular changes and immune infiltration.ER 突变型乳腺癌的肝脏倾向性特征是独特的分子变化和免疫浸润。
Breast Cancer Res Treat. 2024 Jun;205(2):371-386. doi: 10.1007/s10549-024-07255-4. Epub 2024 Mar 1.
通过基因表达谱预测保乳治疗后的局部复发
Breast Cancer Res. 2006;8(5):R62. doi: 10.1186/bcr1614.
4
Co-opting macrophage traits in cancer progression: a consequence of tumor cell fusion?在癌症进展中利用巨噬细胞特征:肿瘤细胞融合的结果?
Contrib Microbiol. 2006;13:138-155. doi: 10.1159/000092970.
5
Germline polymorphisms in SIPA1 are associated with metastasis and other indicators of poor prognosis in breast cancer.SIPA1基因的种系多态性与乳腺癌转移及其他预后不良指标相关。
Breast Cancer Res. 2006;8(2):R16. doi: 10.1186/bcr1389. Epub 2006 Mar 21.
6
Metastasis predictive signature profiles pre-exist in normal tissues.转移预测特征谱在正常组织中预先存在。
Clin Exp Metastasis. 2005;22(7):593-603. doi: 10.1007/s10585-005-6244-6. Epub 2006 Feb 11.
7
VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche.血管内皮生长因子受体1阳性的造血骨髓祖细胞启动前转移生态位。
Nature. 2005 Dec 8;438(7069):820-7. doi: 10.1038/nature04186.
8
Tumour-cell fusion as a source of myeloid traits in cancer.肿瘤细胞融合作为癌症中髓系特征的一个来源。
Lancet Oncol. 2005 Dec;6(12):988-93. doi: 10.1016/S1470-2045(05)70466-6.
9
Sipa1 is a candidate for underlying the metastasis efficiency modifier locus Mtes1.Sipa1是转移效率修饰基因座Mtes1潜在的候选基因。
Nat Genet. 2005 Oct;37(10):1055-62. doi: 10.1038/ng1635. Epub 2005 Sep 4.
10
Genes that mediate breast cancer metastasis to lung.介导乳腺癌转移至肺部的基因。
Nature. 2005 Jul 28;436(7050):518-24. doi: 10.1038/nature03799.